Patents Assigned to Trigen, Inc.
  • Publication number: 20220384848
    Abstract: The disclosure relates to the use of fluorinated ethers such as 1,1,1,3,3,3-hexafluoro-2-methoxypropane (HFMOP) as a reaction solvent to prepare fluorinated dialkyl carbonate and sulfite compounds useful in batteries, and to electrolytes containing fluorinated compounds for use in batteries containing high Ni cathodes and silicon containing anodes.
    Type: Application
    Filed: September 17, 2020
    Publication date: December 1, 2022
    Applicant: E3TRIGEN, INC.
    Inventors: Nicholas BORRERO, Neville PAVRI, Serguei KOVALENKO
  • Patent number: 11041420
    Abstract: A combined power conversion and carbon capture and recycling subsystem including a fossil fueled oxidation unit, a physical adsorbent CO2 capture medium, rotor, motor, heater, CO2 compressor, diffuser and water storage tank. Exhaust gas from fossil fuel oxidation is scrubbed of CO2 via passage across a physical adsorbent and then released from the adsorbent via fuel oxidation waste heat. High CO2 concentration scrubber exhaust air is then compressed and fed to a diffuser which facilitates dissociation of the CO2 into water where it is temporarily stored for use in watering plants. Carbon from fossil fuel is recycled back into the environment and permanently stored as biomass by natural means of photosynthesis.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: June 22, 2021
    Assignee: M-TRIGEN, INC.
    Inventors: Donald Williams, Erik Rodriguez
  • Patent number: 5177017
    Abstract: Genetically engineered E. coli carry vectors containing inserts that code for Clostridium histolyticum collagenase. These inserts code for: (a) a form of collagenase having a molecular weight of about 68,000 daltons in the essential absence of larger forms of collagenase; (b) the 68 kd form of collagenase and a fusion polypeptide consisting of the collagenase protein fused to at least a portion of the .beta.-galactosidase protein of E. coli; or (3) the 68 kd form of collagenase and polypeptides of molecular weight of from above about 68,000 daltons to about 100,000 daltons and having the enzymatic activity of C. histolyticum collagenase as indicated by digestion of .sup.3 H-acetylated collagen and by specific inhibition by 1,10-phenanthroline plus EDTA. The collagenase genes in the transformed E. coli are expressed efficiently in the transformed cells to yield enzymatically active and immunologically cross-reactive collagenase.
    Type: Grant
    Filed: March 22, 1990
    Date of Patent: January 5, 1993
    Assignee: Trigen, Inc.
    Inventors: Hun-Chi Lin, Shau-Ping Lei